These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 20145349)

  • 1. Clinical course of arrhythmogenic right ventricular cardiomyopathy in the era of implantable cardioverter-defibrillators and radiofrequency catheter ablation.
    Komura M; Suzuki J; Adachi S; Takahashi A; Otomo K; Nitta J; Nishizaki M; Obayashi T; Nogami A; Satoh Y; Okishige K; Hachiya H; Hirao K; Isobe M
    Int Heart J; 2010 Jan; 51(1):34-40. PubMed ID: 20145349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).
    Romero J; Grushko M; Briceño DF; Natale A; Di Biase L
    Curr Cardiol Rep; 2017 Sep; 19(9):82. PubMed ID: 28779285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcomes of Radio-Frequency Catheter Ablation on Ventricular Tachycardias Due to Arrhythmogenic Right Ventricular Cardiomyopathy: A Single Center Experience.
    Wei W; Liao H; Xue Y; Fang X; Huang J; Liu Y; Deng H; Liang Y; Liao Z; Liu F; Lin W; Zhan X; Wu S
    PLoS One; 2017; 12(1):e0169863. PubMed ID: 28122031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy.
    Gandjbakhch E; Laredo M; Berruezo A; Gourraud JB; Sellal JM; Martins R; Sacher F; Pison L; Pruvot E; Jáuregui B; Frontera A; Kumar S; Wong T; DellaBella P; Maury P
    Europace; 2021 Sep; 23(9):1428-1436. PubMed ID: 34427302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmogenic right ventricular cardiomyopathy/dysplasia in Saudi Arabia: a single-center experience with long-term follow-up.
    Al-Ghamdi B; Shafquat A; Mallawi Y
    Ann Saudi Med; 2014; 34(5):415-26. PubMed ID: 25827699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, Predictors, and Success of Ventricular Tachycardia Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (from the Nordic ARVC Registry).
    Christiansen MK; Haugaa KH; Svensson A; Gilljam T; Madsen T; Hansen J; Holst AG; Bundgaard H; Edvardsen T; Svendsen JH; Platonov PG; Jensen HK
    Am J Cardiol; 2020 Mar; 125(5):803-811. PubMed ID: 31924321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry.
    Santangeli P; Tung R; Xue Y; Chung FP; Lin YJ; Di Biase L; Zhan X; Lin CY; Wei W; Mohanty S; Burkhardt DJ; Zado ES; Callans DJ; Marchlinski FE; Wu S; Chen SA; Natale A
    JACC Clin Electrophysiol; 2019 Jan; 5(1):55-65. PubMed ID: 30678787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Yin K; Ding L; Li Y; Hua W
    Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment.
    Link MS; Laidlaw D; Polonsky B; Zareba W; McNitt S; Gear K; Marcus F; Estes NA
    J Am Coll Cardiol; 2014 Jul; 64(2):119-25. PubMed ID: 25011714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
    Wichter T; Paul M; Wollmann C; Acil T; Gerdes P; Ashraf O; Tjan TD; Soeparwata R; Block M; Borggrefe M; Scheld HH; Breithardt G; Böcker D
    Circulation; 2004 Mar; 109(12):1503-8. PubMed ID: 15007002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac sympathectomy for refractory ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy.
    Assis FR; Krishnan A; Zhou X; James CA; Murray B; Tichnell C; Berger R; Calkins H; Tandri H; Mandal K
    Heart Rhythm; 2019 Jul; 16(7):1003-1010. PubMed ID: 30677492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and state of the art on the electrophysiologic characteristics and catheter ablation of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Chung FP; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Chiou CW; Chen SA
    J Cardiol; 2015 Jun; 65(6):441-50. PubMed ID: 25818480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of ICD electrograms analysis to distinguish endocardial vs epicardial ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy.
    Kodali S; Shirai Y; Callans DJ; Zado ES; Marchlinski FE; Santangeli P
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1526-1534. PubMed ID: 31187564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry.
    Souissi Z; Boulé S; Hermida JS; Doucy A; Mabo P; Pavin D; Anselme F; Auquier N; Ninni S; Coisne A; Brigadeau F; Deken-Delannoy V; Klug D; Lacroix D
    Europace; 2018 Feb; 20(2):362-369. PubMed ID: 28017936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation of the ventricular tachycardia with arrhythmogenic right ventricular cardiomyopathy using non-contact mapping.
    Yao Y; Zhang S; He DS; Zhang K; Hua W; Chu J; Pu J; Chen K; Wang F; Chen X
    Pacing Clin Electrophysiol; 2007 Apr; 30(4):526-33. PubMed ID: 17437577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion.
    Honarbakhsh S; Protonotarios A; Monkhouse C; Hunter RJ; Elliott PM; Lambiase PD
    Europace; 2023 May; 25(5):. PubMed ID: 37213071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catheter ablation of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy.
    Laredo M; Oliveira Da Silva L; Extramiana F; Lellouche N; Varlet É; Amet D; Algalarrondo V; Waintraub X; Duthoit G; Badenco N; Maupain C; Hidden-Lucet F; Maury P; Gandjbakhch E;
    Heart Rhythm; 2020 Jan; 17(1):41-48. PubMed ID: 31284048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up after radiofrequency catheter ablation of ventricular tachycardia: a successful approach?
    Borger van der Burg AE; de Groot NM; van Erven L; Bootsma M; van der Wall EE; Schalij MJ
    J Cardiovasc Electrophysiol; 2002 May; 13(5):417-23. PubMed ID: 12030520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.